March 12, 2024 Comments Off on New patent expiration for Astrazeneca drug LYNPARZA Posted in: Uncategorized
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug LYNPARZA app…
March 12, 2024 Comments Off on Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs Posted in: Infographic This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…
The post Pharmaceutical companies with the most ‘P…